Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2022 15:01 ET | Source: Gb Sciences

UPDATE: Gb Sciences Issues Shareholder Letter

LAS VEGAS, March 16, 2022 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, today issued a letter to...
March 15, 2022 07:00 ET | Source: Gb Sciences

Gb Sciences Issues Summary Shareholder Letter

LAS VEGAS, March 15, 2022 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, today issued a letter to...
March 01, 2022 07:00 ET | Source: Gb Sciences

Gb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitis

LAS VEGAS, March 01, 2022 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, has been issued a new patent today by the...
November 29, 2021 07:00 ET | Source: Gb Sciences

Gb Sciences Accelerates Drug Development via Innovative Biopharma Technology and Strategic Partnerships

LAS VEGAS, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Recognizing the glacial pace of traditional drug research and development processes and the adverse effect of this on patients, biopharmaceutical company...
November 01, 2021 07:00 ET | Source: Gb Sciences

Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety

LAS VEGAS, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. ("GbS"; OTCQB:GBLX), a leading plant-inspired research and biopharmaceutical drug development company, has initiated new preclinical...